Skip to main content

Advertisement

ADVERTISEMENT

News

News
07/05/2022
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially mediate the relationship between cognitive enhancement therapy (CET) and improved functional capacity in people with schizophrenia, according to a new study.
Cognitive gains partially...
07/05/2022
Psych Congress Network
News
06/16/2022
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over...
06/16/2022
Psych Congress Network
News
06/16/2022
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia,...
06/16/2022
Psych Congress Network
News
12/20/2021
Persistent psychotic-like experiences (PLEs) that are distressing are associated with impairment in children in areas including cognitive ability and psychopathology.
Persistent psychotic-like experiences (PLEs) that are distressing are associated with impairment in children in areas including cognitive ability and psychopathology.
Persistent psychotic-like...
12/20/2021
Psych Congress Network
News
12/01/2021
After the implementation of the CMS public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased — and more so among patients who were Black...
After the implementation of the CMS public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased — and more so among patients who were Black...
After the implementation of the...
12/01/2021
Psych Congress Network
News
11/16/2021
Several long-acting injectable (LAI) antipsychotic medications were associated with a reduced hazard of treatment discontinuation compared with oral olanzapine in US veterans with schizophrenia, according to a study results published in The...
Several long-acting injectable (LAI) antipsychotic medications were associated with a reduced hazard of treatment discontinuation compared with oral olanzapine in US veterans with schizophrenia, according to a study results published in The...
Several long-acting injectable...
11/16/2021
Psych Congress Network
News
10/27/2021
New study shows a diet designed to lower omega-6 fatty acid intake and increase omega-3 fatty acid intake improved mood and pain variability in patients with bipolar disorder.
New study shows a diet designed to lower omega-6 fatty acid intake and increase omega-3 fatty acid intake improved mood and pain variability in patients with bipolar disorder.
New study shows a diet designed...
10/27/2021
Psych Congress Network
News
10/14/2021
Regular exercise is associated with a substantially lower risk of anxiety disorders in both men and women, according to a large population-based study.
Regular exercise is associated with a substantially lower risk of anxiety disorders in both men and women, according to a large population-based study.
Regular exercise is associated...
10/14/2021
Psych Congress Network
News
09/03/2021
Patients with mental health disorders are at higher risk for developing severe cases of COVID-19, according to new research published in JAMA Psychiatry.
Patients with mental health disorders are at higher risk for developing severe cases of COVID-19, according to new research published in JAMA Psychiatry.
Patients with mental health...
09/03/2021
Psych Congress Network
News
09/01/2021
Breaking News: The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
Breaking News: The US FDA has approved Janssen Pharmaceutical’s INVEGA HAFYERA (6-month paliperidone palmitate), a long-acting, atypical antipsychotic for adults with schizophrenia.
Breaking News: The US FDA has...
09/01/2021
Psych Congress Network

Advertisement